UK MINISTER MICHAEL Gove has said there “will be no interruption” to UK vaccine supplies from AstraZeneca after the European Union demanded doses from British plants during a row over supply shortages.
Gove said the “first and most important thing” is that the supply schedule agreed with the UK-based pharmaceuticals giant is honoured so the domestic vaccine rollout can be delivered before neighbouring nations are aided.
EU health commissioner Stella Kyriakides said there have been “constructive” talks with AstraZeneca chief executive Pascal Soriot after telling the firm it is contractually obliged to send jabs produced in the UK to 27 EU member states as the bloc faces supply shortages.
Gove told BBC Radio 4’s Today programme: “First thing, we must make sure that we continue with the effective acceleration of our vaccination programme.
“That relies on the supply schedule that has been agreed to be honoured. That’s the first and most important thing.”
“Secondarily,” he said, the desire is to ensure allies receive vaccines but he added that “I think we best achieve that through dialogue and cooperation and friendship”.
Pressed on whether the government would allow vaccines to go to the EU, he said: “No, the critical thing is we must make sure that the schedule that has been agreed and on which our vaccination programme has been based and planned goes ahead.
“It is the case that the supplies that have been planned, paid for and scheduled should continue, absolutely. There will be no interruption to that.”
Teething issues
Soriot has argued supply chain “teething issues” were fixed in the UK ahead of the bloc because Britain signed a contract three months earlier.
But Kyriakides said: “We reject the logic of first come first served.
“That may work at the neighbourhood butchers but not in contracts.”
She denied the bloc would impose an export ban on vaccines leaving the EU but said the contract signed with AstraZeneca, which worked with Oxford University on its vaccine, contains two factories in the UK.
“There is no hierarchy of the factories,” she said.
“You are aware in the contracts there are four factories listed but it does not differentiate between the UK and Europe.
“The UK factories are part of our advance purchase agreements and that is why they have to deliver,” she added.
During a Downing Street press conference, Prime Minister Boris Johnson declined to get drawn into the row but said the vaccine is being produced in “ever growing quantities in the UK”, adding: “That will accelerate, the production schedules will continue to improve.”
He added: “All I can say is we’re very confident in our supplies, we’re very confident in our contracts and we’re going ahead on that basis.”
In an interview with Italy’s La Repubblica newspaper, Soriot said “we are basically two months behind where we want to be” in supplies due to manufacturing issues in Europe, citing problems in a Belgian plant.
He said there had been “teething issues” in the UK supply chain as well but that the deal with Britain was signed three months ahead of the EU’s.
“So with the UK we have had an extra three months to fix all the glitches we experienced,” he said.
He rejected the suggestion the firm was selling to the highest bidder “because we make no profit everywhere” under the agreement signed with Oxford University.
To embed this post, copy the code below on your site
have your say